2-200892355-A-G
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_001369441.2(NIF3L1):āc.412A>Gā(p.Asn138Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000936 in 1,603,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001369441.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NIF3L1 | NM_001369441.2 | c.412A>G | p.Asn138Asp | missense_variant | 2/7 | ENST00000409020.6 | NP_001356370.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NIF3L1 | ENST00000409020.6 | c.412A>G | p.Asn138Asp | missense_variant | 2/7 | 5 | NM_001369441.2 | ENSP00000386394.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152238Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000125 AC: 3AN: 240062Hom.: 0 AF XY: 0.0000153 AC XY: 2AN XY: 130458
GnomAD4 exome AF: 0.00000689 AC: 10AN: 1451142Hom.: 0 Cov.: 31 AF XY: 0.00000971 AC XY: 7AN XY: 720824
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152238Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74368
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2024 | The c.412A>G (p.N138D) alteration is located in exon 2 (coding exon 1) of the NIF3L1 gene. This alteration results from a A to G substitution at nucleotide position 412, causing the asparagine (N) at amino acid position 138 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at